- Home
- Current Affairs
- Current News
- Peptris Secures Rs. 86 Crore Support for AI-Based Drug Discovery
State In News
State In News
State In News
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chhattisgarh
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu And Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttarakhand
- West Bengal
Peptris Secures Rs. 86 Crore Support for AI-Based Drug Discovery
- 12 Oct 2026
On October 12, 2026, the Technology Development Board (TDB) entered into Rs. 86 crore agreement with Bengaluru-based Peptris Technologies for AI-driven drug development.
Key Facts
- Objective: To boost novel drug development in India by advancing AI-discovered candidate molecules from laboratory research to Clinical Trial readiness.
- Financial Assistance: Assistance of Rs. 86 crore was designated for the Rs. 172 crore VIGOR project under the Research, Development, and Innovation (RDI) Fund.
- VIGOR Program: Aimed at taking four AI-discovered experimental drugs from TRL-4 to TRL-6 through pre-clinical studies, scientific validation, and clinical trial preparation.
- Experimental Drugs: The program includes PEPR111, PEPRX101, PEPR202, and PEPR112 for potential treatment of neuromuscular disorders & cancer, alopecia, neuropathy, and DMD, respectively.
